국내학술대회

  • 학술행사
  • 국내학술대회
  • 국내학술대회

대한부인종양학회 학술대회

<<KSGO 2024>>

일시 : 2024-04-26 (금) ~ 2024-04-27 (토)
장소 : 부산 벡스코(BEXCO)
4/26(금) 08:30 - 09:40 / 5A Hall
SESSION Master Class Yong Man Kim
Ulsan University, Korea)
Takayuki Enomoto
(Niigata University, Japan)
08:30 - 08:50 AI-enhanced pathology: pathway to precision in oncology SooIck Cho
(Lunit Inc., Korea)
08:50 - 09:00 Designated discussion Sung Taek Park
(Hallym University, Korea)
09:00 - 09:05 Floor discussion
09:05 - 09:25 Locally advanced cervical cancer management Dimitrios Nasioudis
(University of Pennsylvania, USA)
09:25 - 09:35 Designated Discussion Tae-Wook Kong
(Ajou University, Korea)
09:35 - 09:40 Floor discussion
4/26(금) 09:50 - 10:50 / 5A Hall
SESSION Plenary I Dong-Choon Park
(Catholic University, Korea)
Mikio Mikami
(Tokai University, Japan)
09:50 - 10:00 A single-arm, phase II study of niraparib and bevacizumab maintenance in patients with platinum-sensitive, recurrent ovarian cancer previously treatted with a PARP inhibitor (KGOG 3056/NIRVANA-R) Hyun-Woong Cho
(Korea University, Korea)
10:00 - 10:05 Distallate discussion Sung Jong Lee
(Catholic University, Korea)
10:05 - 10:10 Floor discussion
10:10 - 10:20 Predicting microsatellite instability status in endometrial cancer using F-18 Fluorodeoxyglucose positron emission tomography/computed tomography radiomics Jong Mi Kim
(Kyungpook National University, Korea)
10:20 - 10:25 Distallate discussion Yong Jae Lee
(Yonsei University, Korea)
10:25 - 10:30 Floor discussion
10:30 - 10:40 Oncologic outcomes and the Impact of minimally invasive surgery in early-stage cervical cancer patients undergoing radical trachelectomy: a Korean Gynecologic Oncology Group Study (KGOG 1048) Dae-Yeon Kim
(Ulsan University, Korea)
10:40 - 10:45 Distallate discussion Dimitrios Nasioudis
(University of Pennsylvania, USA)
10:45 - 10:50 Floor discussion
4/26(금) 11:10 - 12:10 / 5A Hall
SESSION Plenary II Jae Kwan Lee
(Korea University, Korea)
Yang Xiang
(Peking Union Medical College, China)
11:10 - 11:20 Development of a novel ex-vivo anticancer drug screening system for precision medicine in ovarian cancer patients Jeong-Won Lee
(Sungkyunkwan University, Korea)
11:20 - 11:25 Distallate discussion Jae Hong No
(Seoul National University, Korea)
11:25 - 11:30 Floor discussion
11:30 - 11:40 Analysis of improvement in overall survival rate when cervical cancer patients participate in clinical trials Yong Man Kim
(Ulsan University, Korea)
11:40 - 11:45 Distallate discussion Hiroaki Kobayashi
(Kagoshima University, Japan)
11:45 - 11:50 Floor discussion
11:50 - 12:00 Emerging role of immuno-oncologics in cervical cancer Yang Xiang
(Peking Union Medical College, China)
12:00 - 12:05 Distallate discussion So-Jin Shin
(Keimyung University, Korea)
12:05 - 12:10 Floor discussion

철회

11:50 - 12:00
Nomogram for long-term recurrence free survival after fertility-sparing treatment with progestin in early endometrial cancer patients :
Gynecologic Oncology Research Investigators coLLaborAtion study (GORILLA-2002)
A Jin Lee
(Konkuk University, Korea)
4/26(금) 12:10 - 12:40 / 5A Hall
SESSION Industry Session I Soo-Young Hur
(Catholic University, Korea)
Tae Jin Kim
(Konkuk University, Korea)
12:10 - 12:25 Enhancing HPV management through risk stratification: the role of dual staining with p16 and Ki-67 Kyung-Jin Min
(Korea University, Korea)
12:25 - 12:40 Illuminating for ECpatients: unveiling a new treatment paradigm in 1L EC Kidong Kim
(Seoul National University, Korea)
4/26(금) 13:30 - 14:10 / 5A Hall
SESSION Focused Plenary Session-Ovary I Suk-Joon Chang
(Ajou University, Korea)
Jeong-Won Lee
(Sungkyunkwan University, Korea)
13:30 - 13:38 Distinct immune characteristics and differential anti-PD-1-mediated reinvigoration potential of CD8+ TILs based on BRCA1/2 mutation status in epithelial ovarian cancer Junsik Park
(Soonchunhyang University, Korea)
13:38 - 13:46 A comprehensive proteomics study to predict therapeutic responses to PARP inhibitors in high-grade serous ovarian cancer Se Ik Kim
(Seoul National University, Korea)
13:46 - 13:54 Development of a next-generation RNA sequencing-based deep-learning model predicting risk of chemoresistance in high-grade serous ovarian carcinoma Se Ik Kim
(Seoul National University, Korea)
13:54 - 14:02 Oncogenic pathway landscape of ovarian cancer and correlation with clinical prognosis Young-Jae Lee
(Ulsan University, Korea)
14:02 - 14:10 Floor discussion
4/26(금) 14:10 - 14:50 / 5A Hall
SESSION Focused Plenary Session-Ovary II Ju-Won Roh
(CHA University, Korea)
Sunghoon Kim
(Yonsei University, Korea)
14:10 -14:18 Surgical outcomes of interval debulking surgery after neoadjuvant chemoimmunotherapy for advanced-stage ovarian cancer Dahye Lee
(Yonsei University, Korea)
14:18 - 14:26 Effect of quality control program on surgical management in advanced ovarian cancer Bo Ra Kim
(Ewha Womans University, Korea)
14:26 - 14:34 FOXA1 FOXA1 gene that plays an important role in ovarian cancerthat plays an important role in ovarian cancer Eunjung Yang
(Soonchunhyang University, Korea)
14:34 - 14:42 Hyperthermic intraperitoneal chemotherapy for stage IV epithelial ovarian cancer: a critical appraisal of indications and clinical implications Joo-Hyuk Son
(Ajou University, Korea)
14:42 - 14:50 Floor discussion
4/26(금) 13:30 - 14:10 / 321+322+323+324
SESSION Focused Plenary Session-Uterine Corpus Jae-Hoon Kim
(Yonsei University, Korea)
Dae Hoon Jeong
(Inje University, Korea)
13:30 - 13:38 Investigating L1CAM and β-catenin as prognostic indicators in fertility-sparing endometrial cancer treatment Ok-Ju Kang
(Ulsan University, Korea)
13:38 - 13:46 Hormone replacement therapy and risks of various cancers in postmenopausal women with de-novo or a history of endometriosis Banghyun Lee
(Inha University, Korea)
13:46 - 13:54 Improving preoperative identification of uterine sarcomas: analysis of clinical and imaging characteristics Seungmee Lee
(Keimyung University, Korea)
13:54 - 14:02 Correlation between mismatch repair status and lymph node metastasis in endometrial cancer Minjeong Park
(Inje University, Korea)
14:02 - 14:10 Floor discussion
4/26(금) 14:10 - 14:50 / 321+322+323+324
SESSION Focused Plenary Session-Cervix Sang Young Ryu
(Korea Cancer Center, Korea)
Dae-Yeon Kim
(Ulsan University, Korea)
14:10 - 14:18 Optimal dietary intake of riboflavin associated with lower risk of cervical cancer in Korea : Korean national health and nutrition examination survey 2010-2021 Seon-Mi Lee
(Korea University, Korea)
14:18 - 14:26 Impact of metformin on survival outcome in advanced cervical cancer: A Korean and Japanese Gynecologic Oncology Group (KGOG & JGOG) collaboration study Min-Hyun Baek
(Kangwon National University, Korea)
14:26 - 14:34 A feasibility study of upcycled smartphone-based colposcopy for visual inspection of cervix performed by community healthcare workers in rural Vietnam Ga Won Yim
(Dongguk University, Korea)
14:34 - 14:42 A tissue factor bi-specific T cell engager provides effective targeting and cytotoxicity against cervical cancer cell lines Hye-yon Cho
(Hallym University, Korea)
14:42 - 14:50 Floor discussion
4/26(금) 15:20 - 15:52 / 5A Hall
SESSION Focused Plenary Session-Others Jong-Min Lee
(Kyung Hee University, Korea)
Seob Jeon
(Soonchunhyang University, Korea)
15:20 - 15:28 Assessing adverse pregnancy outcomes and fetal malformations in cancer diagnosed during pregnancy Yung-Taek Ouh
(Korea University, Korea)
15:28 - 15:36 Regularity of cervical cancer screening in Korea: analysis using national public data for 12 years Taehyun Kim
(Konyang University, Korea)
15:36 - 15:44 Preliminary study of combination treatment of immune checkpoint inhibitors and modulated electro-hyperthermia in recurrent gynecologic malignancies Jihyun Moon
(CHA University, Korea)
15:44 - 15:52 Floor discussion

철회

15:36 - 15:44
Lymphedema in Gynecological cancer survivor ; A Nationwide Cohort Study Su Jeong Lee
(Catholic University, Korea)
4/26(금) 16:00 - 16:25 / Line 1 at the backside of 5A Hall
SESSION Featured Poster Session-Line 1 Sang Il Park
(DIRAMS Cancer Center, Korea)
16:00 - 16:05 The efficacy of subsequent chemotherapy in ovarian cancer patients who progressed in prior PARPi Jung Chul Kim
(Yonsei University, Korea)
16:05 - 16:10 Anti-cancer effect of benzimidazole derivative BNZ-111 on paclitaxel-resistant ovarian cancer Jeong-Won Lee
(Sungkyunkwan University, Korea)
16:10 - 16:15 Application of machine learning algorithms for risk stratification and efficacy evaluation in cervical cancer screening among low- grade abnormal cytology population: evidence from the Korean HPV cohort study Heekyoung Song
(Catholic University, Korea)
16:15 - 16:20 Risk factors for the recurrence in patients with early endometrioid endometrial cancer achieving complete remission for fertility-sparing hormonal treatment Eun Bi Jang
(Konkuk University, Korea)
16:20 - 16:25 Consideration of fertility-preserving treatment for cervical cancer based on the evolution Masato Tamate
(Sapporo Medical University, Japan)

철회

16:00 - 16:05
Serial circulating-tumor DNA analysis with a tumor naïve next-generation sequencing panel detects minimal residual disease and predicts outcome in ovarian cancer Yoo-Na Kim
(Yonsei University, Korea)

철회

16:20 - 16:25
Development of a next-generation sequencing cancer panel‐based homologous recombination deficiency test in epithelial ovarian cancer Se Ik KIM
(Seoul National University, Korea)

철회

16:25 - 16:30
ZBTB8A promotes ovarian cancer metastasis through interacting with ACOT12 Zhang Jinging
(Shandong University, China)
4/26(금) 16:00 - 16:30 / Line 2 at the backside of 5A Hall
SESSION Featured Poster Session-Line 2 Taek Sang Lee
(Seoul National University, Korea)
16:00 - 16:05 Identification of Tumor-Specific Genes in Cervix sample of Ovarian Cancer Patients Chi-Son Chang
(Chung-Ang University, Korea)
16:05 - 16:10 A phase 1/2a, dose-escalation, safety, and preliminary efficacy randomized trial of the RKP00156 vaginal tablet in healthy women and patients with cervical intraepithelial neoplasia 2 Sohyeon Jeong
(Korea University, Korea)
16:10 - 16:15 Usefulness of magnetic resonance imaging before hysterectomy in detecting occult invasive cervical cancer in patients scheduled for hysterectomy due to high-grade and microinvasive cervical disease Jimin Lee
(Ajou University, Korea)
16:15 - 16:20 Multicenter retrospective analysis of neuroendocrine carcinoma of the cervix: clinical behavior, treatment patterns, and prognostic outcomes Takuya Kuboya
(University of Tsukuba, Japan)
16:20 - 16:25 Combined oral contraceptives and endometrial cancer among Southeast Asian women: A secondary analysis of multicenter case-control study Kuntima Kantawee
(Khon Kaen University, Thailand)
16:25 - 16:30 Knowledge of human papillomavirus vaccine and infection in secondary school students from northern thailand: post covid-19 era Napat Likkasittipan
(Chiang Mai University, Thailand)
4/26(금) 13:30 - 14:50 / 121+122
SESSION Overseas Ga Won Yim
(Dongguk University, Korea)
Hiroaki Kobayashi
(Kagoshima University, Japan)
13:30 - 13:38 Comparison of survival outcomes between sequential and ‘sandwich’ sequencing of adjuvant chemo-radiotherapy in advanced stage endo metrial carcinoma patients at phramongkutklao hospital and national cancer institute Ekasit Chaiamonsup
(Phramongkutklao Hospital, Thailand)
13:38 - 13:40 Floor discussion
13:40 - 13:48 Toripalimab combined with bevacizumab and chemotherapy as first-line treatment for refractory, recurrent or metastatic cervical cancer: a single-arm, open-label, phase II trial Chen Li
(Peking Union Medical College, China)
13:48 - 13:50 Floor discussion
13:50 - 13:58 UBE2T-mediated stemness enhancement: unraveling platinum resistance mechanisms in ovarian cancer Jingying Chen
(Shandong University, China)
13:58 - 14:00 Floor discussion
14:00 - 14:08 Estrogen receptor downregulates programmed death ligand-1 and associated with clinicopathological of type 1 endometrial carcinoma Setyo Teguh Waluyo
(Lambung Mangkurat University, Indonesia)
14:08 - 14:10 Floor discussion
14:10 - 14:18 Stearate-rich diet and oleate restriction directly inhibit tumor growth via the unfolded protein response Jumpei Ogura
(Kyoto University, Japan)
14:18 - 14:20 Floor discussion
14:20 - 14:28 Factors influencing single agent methotrexate chemotherapy resistance in low risks gestational trophoblastic neoplasia in indonesia single center trophoblast study Febia Erfiandi
(Padjadjaran University, Indonesia)
14:28 - 14:30 Floor discussion
14:30 - 14:38 Survival in patients with recurrent or progressive uterine carcinosarcoma Kanakarn Wangrangsimakul
(Songkhlanagarind Hospital, Thailand)
14:38 - 14:40 Floor discussion
14:40 - 14:48 Trends and outcomes of minimally invasive surgery for endometrial cancer in kanagawa academic institutions: a retrospective observational study Jun Takeuchi
(St. Marianna University, Japan)
14:48 - 14:50 Floor discussion
4/26(금) 15:20 - 16:00 / 321+322+323+324
SESSION Al in Gyn Oncology Sung Jong Lee
(Catholic University, Korea)
Banghyun Lee
(Inha University, Korea)
15:20 - 15:30 Pelvic ultrasound-based deep learning models for accurate diagnosis of ovarian cancer: retrospective multicenter study Hyun-Woong Cho
(Korea University, Korea)
15:30 - 15:33 Floor discussion
15:33 - 15:43 Prognostic implications of body composition in cervical cancer patients who underwent concurrent chemoradiation therapy as a primary treatment: a clinical research utilizing an artificial intelligence-based volumetrics Hyunji Lim
(CHA University, Korea)
15:43 - 15:46 Practical use of ChatGPT and generative AI on clinical research Jeong-Moo Lee
(Seoul National University, Korea)
15:56 - 16:00 Floor discussion
4/26(금) 15:20 - 16:00 / 121+122
SESSION SHAPE Sokbom Kang
(National Cancer Center, Korea)
Won Moo Lee
(Hanyang University, Korea)
15:20 - 15:30 On the radical hysterectomy Yusuke Kobayashi
(Keio University, Japan)
15:30 - 15:40 Pros Se Ik Kim
(Seoul National University, Korea)
15:40 - 15:50 Cons Jeong-Yeol Park
(Ulsan University, Korea)
15:50 - 16:00 Floor discussion
4/26(금) 16:40 - 17:40 / 5A Hall
SESSION Multidisciplinary Tumor Board for Cervical Cancer Yoo-Young Lee
(Sungkyunkwan University, Korea)
Youn Jin Choi
(Catholic University, Korea)
16:40 - 17:40 Advancing treatment for HPV-independent cervical cancer and enhancing CCRT outcomes Hyun-Soo Kim
(Sungkyunkwan University, Korea)

Ji Ho Nam
(Pusan National Univeristy, Korea)

Sung Taek Park
(Hallym University, Korea)

Jihye Kim
(Chung-Ang University, Korea)
4/26(금) 16:10 - 17:40 / 321+322+323+324
SESSION Nursing Session Gie Ok Noh
(Konyang University, Korea)
Dong Soo Suh
(Pusan University, Korea)
16:10 - 16:30 Application of targeted therapy and immunotherapy in gynecological cancer treatment Sun Young Yu
(Asan Medical Center, Korea)
16:30 - 16:50 Access to the adverse effects of immunotherapy and targeted therapy Joohyun Kim
(Samsung Medcial Center, Korea)
16:50 - 17:10 Fertility preservation for young women with gynecologic cancer Hyun-Woong Cho
(Korea University, Korea)
17:10 - 17:30 Rehabilitation and exercise for gynecologic cancer survivors Heung Soo Kim
(Korea Cancer Rehabiliation Institute, Korea)
17:30 - 17:40 Discussion
17:40 Closing Gie Ok Noh
(Konyang University, Korea)
4/27(토) 09:00 - 10:00 / 5A Hall
SESSION Hereditary Gynecologic Cancer Myung Cheol Lim
(National Cancer Center, Korea)
Eun-Ji Nam
(Yonsei University, Korea)
09:00 - 09:15 Update of hereditary gynecologic cancer guideline Hyeong In Ha
(Pusan National University, Korea)
09:15 - 09:20 Floor discussion
09:20 - 09:35 Clinical application of BRCA/HRD in the management of ovarian cancer Sojin Shin
(Keimyung University, Korea)
09:35 - 09:40 Floor discussion
09:40 - 09:55 Clinical application of MMR in the management of endometrial cancer Ji Hyun Kim
(Natioanl Cancer Center, Korea)
09:55 - 10:00 Floor discussion
4/27(토) 10:00 - 10:50 / 5A Hall
SESSION JGO Workshop Myung Cheol Lim
(National Cancer Center, Korea)
Dong Hoon Suh
(Seoul National University, Korea)
10:00 - 10:30 Utilization of Generative AI in Medical Research: A Case Study Seng Chan You
(Yonsei University, Korea)
10:30 - 10:50 Q&A
4/27(토) 09:00 - 09:40 / 121+122
SESSION Informed Consent Forms for Gynecologic Cancer Surgery: Laparoscopic Hysterectomy and Vulvar Cancer Jong-Min Lee
(Kyung Hee University, Korea)
Kwang Beom Lee
(Gachon University, Korea)
09:00 - 09:30 Informed consent forms for gynecologic cancer surgery: laparoscopic hysterecotmy and vulvar cancer Geonwoo Lee
(Chungnam National University, Korea)
09:30 - 09:40 Distillate discussion Soohyun Oh
(Gachon University, Korea)
4/27(토) 10:00 - 12:00 / 121+122
SESSION Understanding Gynecologic Cancer Dae Hoon Jeong
(Inje University, Korea)
10:00 - 10:25 Understanding cervical cancer Sang-Il Park
(DIRAMS Cancer Center, Korea)
10:00 - 10:25 Panel discussion Tae Hwa Lee
(Kosin University, Korea)
10:25 - 10:50 Understanding endometrial cancer Yong Jung Song
(Pusan National University, Korea)
10:25 - 10:50 Panel discussion Eun Hyun Lee
(Inje University, Korea)
10:50 - 11:15 Understanding ovarian cancer Dong soo Suh
(Pusan National University, Korea)
10:50 - 11:15 Panel discussion Hyun-Jin Roh
(Ulsan University, Korea)
11:15 - 11:40 Prevention of gynecologic cancer Jung Mi Byun
(Inje University, Korea)
11:15 - 11:40 Panel discussion Jung-Woo Park
(Dong-A University, Korea)
11:40 - 12:00 Q&A and Lucky Draw
4/27(토) 10:00 - 12:00 / 321+322+323+324
SESSION The Second Public Hearing for the Establishment of Clinical Guidelines for HPV Testing
10:00 - 10:05 Greetings from the President of the Korean Society of Gynecologic Oncology Jae-Weon Kim
(Seoul National University, Korea)
PART 1. Key Questions Regrading HPV Testing Guidelines Ju-Hyun Kim (Ulsan University, Korea)
10:05 - 10:20 Target population and timing for HPV testing for cervical cancer screening Se Ik Kim
(Seoul National University, Korea)
10:20 - 10:35 Clinical application of various HPV testing methods Yung-Taek Ouh
(Korea University, Korea)
10:35 - 10:50 Cost-effectiveness analysis of HPV testing in cervical cancer screening Min-Woo Jo
(Ulsan University, Korea)
10:50 - 11:00 Discussion
PART 2. Plans for the Establishment of Clinical Guidelines for HPV Testing & Discussion Shin Wha Lee (Ulsan University, Korea)
11:00 - 11:50 Report on the progress of the 1st Public Hearing for the Establishment of clinical guidelines for HPV testing Development and implementation plan for clinical guidelines for HPV testing discussion
11:50 - 12:00 Future schedules
4/27(토) 11:20 - 12:40 / 5A Hall
SESSION Immuno-oncologics in Gynecologic Cancer Min Kyu Kim
(Sungkyunkwan University, Korea)
Eun-Ju Lee
(Chung-Ang University, Korea)
11:20 - 11:35 Advanced/recurrent cervical cancer Kyung Hee Han
(CHA University, Korea)
11:35 - 11:40 Floor discussion
11:40 - 11:55 Advanced/recurrent endometrial cancer Jun Sik Park
(Soonchunhyang University, Korea)
11:55 - 12:00 Floor discussion
12:00 - 12:15 Major three A/E: management tips Hyunji Lim
(CHA Univeristy, Korea)
12:15 - 12:20 Floor discussion
12:20 - 12:35 Beyond the immune-oncologics in gynecologic cancer Yong Jae Lee
(Yonsei University, Korea)
12:35 - 12:40 Floor discussion
4/27(토) 12:40 - 13:10 / 5A Hall
SESSION Industry Session II Yong Beom Kim
(Seoul National University, Korea)
Keun Ho Lee
(Catholic University, Korea)
12:40 - 12:55 Pembrolizumab in combination with CCRT: the next frontier for LACC Sojin Shin
(Keimyung University, Korea)
12:55 - 13:10 Niraparib, 1L maintenance treatment for newly diagnosed OC focused on BRCAmut and HRD Joseph Noh
(Seoul University, Korea)
4/27(토) 13:50 - 14:40 / 5A Hall
SESSION Molecular Tumor Board Min Chul Choi
(CHA University, Korea)
13:50 - 14:20 Experience of operating the molecular tumor board Jihong Liu
(Sun Yat-sen University Cancer Center, China)
14:20 - 14:30 Case presentation Dong-Won Hwang
(Inje University, Korea)
14:30 - 14:40 Floor discussion
4/27(토) 13:50 - 14:35 / 321+322+323+324
SESSION Surgical Film Sang Wun Kim
(Yonsei University, Korea)
Jae-Yun Song
(Korea University, Korea)
13:50 - 14:02 Video demonstration of vNOTES pelvic lymphadenectomy in gynecologic cancer Keun Ho Lee
(Catholic University, Korea)
14:02 - 14:05 Floor discussion
14:05 - 14:12 Metastatic pancreatic carcinoma to the uterine cervix, vNOTES contributed to the diagnosis.:A case report. Yu Kamishita
(Saga-Ken Medical Centre Koseikan, Japan)
14:12 - 14:15 Floor discussion
14:22 - 14:25 Floor discussion
14:25 - 14:32 Ureteroureterostomy during laparoscopic radical hysterectomy Chul Min Park
(Jeju National University, Korea)
14:32 - 14:35 Floor discussion

철회

14:15 - 14:22
Robot assisted laparoscopic surgery in loco-regionally recurrent ovarian cancer Jiwon Mun
(Catholic University, Korea)
4/27(토) 15:00 - 16:15 / 5A Hall
SESSION Gynecologic Cancer Pathology Jeong-Yeol Park
(Ulsan University, Korea)
Seung-Hyuk Shim
(Konkuk University, Korea)
15:00 - 15:20 Interpretation of Endometrial Curettage Hyun-Soo Kim
(Sungkyunkwan University, Korea)
15:20 - 15:25 Floor discussion
15:25 - 15:45 Practical Approach of Molecular Classification in Endometrial Cancer Ha Young Woo
(Chung-Ang University, Korea)
15:45 - 15:50 Floor discussion
15:50 - 16:10 2023 Revised FIGO Stage of Endometrial Cacner Hye Eun Park
(Seoul University, Korea)
16:10 - 16:15 Floor discussion

연도별 학술행사

제26차 대한부인종양학회 추계심포지엄 E-Conference

제26차 대한부인종양학회 추계심포지엄 E-Conference
일시 : 2020년 10월 31일(토)

강의록 다운로드

통합 program
통합 Program
사회: 서동훈 (대한부인종양학회 사무총장)
08:30-08:40 Opening Remarks 김승철 (대한부인종양학회 회장)
Session I-1제4회 부인종양의학상 시상식 및 발표 좌장: 배덕수 (성균관의대)
김영탁 (울산의대)
08:40-08:50 부인종양의학상 학술대상 수상자 논문 발표
08:50-09:00 부인종양의학상 젊은의학자상 수상자 논문 발표
Session I-2The Best Real-World Practice 좌장: 김영태 (연세의대)
김재원 (서울의대)
09:00-09:20 The best type of PARPi for the best time in the management of ovarian cancer 이신화 (울산의대)
09:20-09:40 The best type of PD1 inhibitor for the best time in the management of cervical cancer 이원무 (한양의대)
09:40-10:00 PD1 inhibitor with/without multiple kinase inhibitor for the treatment of endometrial cancer 이유영 (성균관의대)
10:00-10:20 Which phase II/III RCTs in ovarian cancer will be finalized in 5 year? 유헌종 (충남의대)
10:20-10:30 Discussion
Session I-3Clinical Studies Update in Gynecologic Cancer 좌장: 남계현 (순천향의대)
이종민 (경희의대)
10:30-10:50 Secondary cytoreductive surgery in recurrent epithelial ovarian cancer 이산희 (연세원주의대)
10:50-11:10 Tertiary cytoreductive surgery in recurrent epithelial ovarian cancer 임명철 (국립암센터)
11:10-11:30 ADC(Antibody-Drug Conjugate) in management of ovarian cancer 조한별 (연세의대)
11:30-11:50 Novel discoveries in endometrial cancer: are we making progress? 이성종 (가톨릭의대)
11:50-12:10 Screening for lynch syndrome in endometrial cancer patients 김미경 (이화의대)
12:10-12:20 Discussion
Luncheon Symposium 좌장: 김기형 (부산의대)
12:20-12:40 Rationale for earlier intervention with PARP inhibitor and importance of personalized medicine in ovarian cancer 김기동 (서울의대)
12:40-13:40 Lunch
학술 program
학술 Program
사회: 서동훈 (대한부인종양학회 사무총장)
Session II-1International Issues
13:40-14:00 Quality control of surgery in advanced epithelial ovarian cancer 좌장: 장석준 (아주의대)
Christina Fotopoulou
(Imperial College London, UK)
14:00-14:05 Discussion 김희승 (서울의대)
14:05-14:25 Current and future considerations for the use of checkpoint inhibitors in gynecologic cancers 좌장: 강석범 (국립암센터)
David O'Malley
(The Ohio State University, USA)
14:25-14:30 Discussion 어경진 (연세의대)
14:30-14:45 An introduction to NUWA-National gynecological oncology research and patient management platform 좌장: 이택상(서울의대)
Qinglei Gao
(Huazhong University, China)
14:45-14:50 Discussion 김세익 (서울의대)
Session II-2Special Lectures 좌장: 허수영 (가톨릭의대)
이재관 (고려의대)
14:50-15:10 9가 자궁경부암 예방백신 허가 사항 - 진료권고안 업데이트 민경진 (고려의대)
15:10-15:30 Future treatment strategy based on PARPi frontline ovaian cancer Antonio González-MartÍn
(ClÍnica Universidad de Navarra, Spain)
15:30-15:50 Patient blood management as a standard of care 이정재 (순천향의대)
15:50-16:00 Perioperative use of IV iron in gynecologic cancer patients (증례발표) 서동훈 (서울의대)
16:00-16:30 Clinical impact of febrile neutropenia with ovarian cancer by pegfilgrastim 최철훈 (성균관의대)
16:30-16:40 Discussion
16:40 Closing Remarks
16:50-17:10 정기총회(ZOOM Meeting)
학술 program/간호분과 program
간호분과 Program
사회: 문혜성 (이대목동병원)
13:30-13:40 Opening Remarks 노주희
(대한부인종양학회 간호분과소위원장)
Nursing Session I-1Key Updates in Hereditary Gynecologic Cancer 좌장: 노주희 (전북대학교 간호대학)
이정원 (성균관의대)
13:40-14:00 Recent clinical trial outcome based on the hereditary predisposition of gynecologic cancer 신소진 (계명의대)
14:00-14:20 Clinical significance and reclassification of PV/LPV/VUS of BRCA 1/2 남은지 (연세의대)
14:20-14:40 What should we know about real-world genetic counseling of hereditary gynecologic cancer? 정고운 (국립암센터)
14:40-14:50 Discussion
Nursing Session I-2New Trend in Genetic Care in Gynecologic Oncology 좌장: 노기옥 (건양대학교 간호대학)
김태진 (건국의대)
14:50-15:10 Genome & health record 홍경원 (테라젠이텍스)
15:10-15:30 New treatment for hereditary gynecologic cancer 유선영 (서울아산병원)
15:30-15:50 Knowledge and anxiety in hereditary ovarian cancer patients 이상희 (국립암센터)
15:50-16:00 Discussion

연도별 학술행사

2021년 JGO Workshop
Date: April 18(Sun), 2021 / Venue: Seoul Dragon City, 3F Shilla Room

TOP